These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34228248)

  • 1. Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism.
    Yamashita Y; Amano H; Morimoto T; Kadota K; Hata R; Matsushita K; Osakada K; Sano A; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Inoko M; Tada T; Chen PM; Murata K; Tsuyuki Y; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Kato T; Ono K; Kimura T;
    J Thromb Thrombolysis; 2022 Jan; 53(1):182-190. PubMed ID: 34228248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.
    Kim K; Yamashita Y; Morimoto T; Kitai T; Yamane T; Ehara N; Kinoshita M; Kaji S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Furukawa Y; Kimura T;
    Thromb Haemost; 2019 Sep; 119(9):1498-1507. PubMed ID: 31230344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants.
    Kaneda K; Yamashita Y; Morimoto T; Chatani R; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Takada T; Otsui K; Kimura T;
    Eur J Intern Med; 2023 Dec; 118():59-72. PubMed ID: 37574348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry.
    Yamashita Y; Morimoto T; Klok FA; Barco S; Nishimoto Y; Kato T; Ono K; Kimura T;
    J Thromb Thrombolysis; 2022 Oct; 54(3):524-534. PubMed ID: 35713842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism　- From the COMMAND VTE Registry.
    Nishimoto Y; Yamashita Y; Kim K; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    Circ J; 2020 Oct; 84(11):2006-2014. PubMed ID: 33012736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition of management strategies and long-term outcomes in cancer-associated venous thromboembolism from the warfarin era to the direct oral anticoagulant era.
    Chatani R; Yamashita Y; Morimoto T; Kaneda K; Mushiake K; Kadota K; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Kimura T;
    Eur J Intern Med; 2024 May; 123():72-80. PubMed ID: 38278660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and long-term outcomes of patients with venous thromboembolism: From the COMMAND VTE Registry.
    Takahashi K; Yamashita Y; Morimoto T; Tada T; Sakamoto H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Chen PM; Murata K; Tsuyuki Y; Nishimoto Y; Sakamoto J; Togi K; Mabuchi H; Takabayashi K; Kato T; Ono K; Kimura T;
    Int J Cardiol; 2023 Jul; 383():89-95. PubMed ID: 37156304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprocedural management and clinical outcomes of invasive procedures after venous thromboembolism: from the COMMAND VTE registry.
    Hata R; Yamashita Y; Morimoto T; Kadota K; Amano H; Murai R; Osakada K; Sano A; Takase T; Hiramori S; Kim K; Oi M; Akao M; Doi K; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Tsujisaka Y; Seko Y; Matsushita K; Yoneda F; Kato T; Ono K; Kimura T;
    J Thromb Thrombolysis; 2022 Feb; 53(2):540-549. PubMed ID: 34524599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation Therapy for Venous Thromboembolism in the Real World　- From the COMMAND VTE Registry.
    Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Konishi T; Akao M; Kobayashi Y; Inoue T; Oi M; Izumi T; Takahashi K; Tada T; Chen PM; Murata K; Tsuyuki Y; Sakai H; Saga S; Sasa T; Sakamoto J; Yamada C; Kinoshita M; Togi K; Ikeda T; Ishii K; Kaneda K; Mabuchi H; Otani H; Takabayashi K; Takahashi M; Shiomi H; Makiyama T; Ono K; Kimura T;
    Circ J; 2018 Apr; 82(5):1262-1270. PubMed ID: 29576597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct oral anticoagulant-associated bleeding complications in patients with gastrointestinal cancer and venous thromboembolism.
    Nishimoto Y; Yamashita Y; Morimoto T; Chatani R; Kaneda K; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Sato Y; Watanabe T; Yamada T; Fukunami M; Kimura T;
    Eur J Intern Med; 2024 Sep; 127():74-83. PubMed ID: 38664165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-Associated Venous Thromboembolism in the Real World　- From the COMMAND VTE Registry.
    Sakamoto J; Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Tamura T; Nakagawa Y; Kimura T;
    Circ J; 2019 Oct; 83(11):2271-2281. PubMed ID: 31548438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of recurrent venous thromboembolism and bleeding in patients with interstitial lung disease: a cohort study.
    Le Mao R; Ropars T; Tromeur C; Barnier A; Hourmant B; Guegan M; Jimenez D; Leroyer C; Lacut K; Couturaud F
    J Thromb Thrombolysis; 2022 Jan; 53(1):67-73. PubMed ID: 34232453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.
    Carrier M; Le Gal G; Wells PS; Rodger MA
    Ann Intern Med; 2010 May; 152(9):578-89. PubMed ID: 20439576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of oral anticoagulation treatment beyond 1 year after venous thromboembolism in patients at intermediate recurrence risk.
    Johnsen SP; Rasmussen TB; Falstie-Jensen AM; Harboe L; Stynes G; Dybro L; Hansen ML; Brandes A; Grove EL; Münster AM
    Basic Clin Pharmacol Toxicol; 2021 Sep; 129(3):210-220. PubMed ID: 34128322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism.
    Vedovati MC; Giustozzi M; Munoz A; Bertoletti L; Cohen AT; Klok FA; Connors JM; Bauersachs R; Brenner B; Campanini M; Becattini C; Agnelli G
    Eur J Intern Med; 2023 Jun; 112():29-36. PubMed ID: 36774305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
    Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
    J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.
    Schnegg-Kaufmann A; Calzavarini S; Limacher A; Mean M; Righini M; Staub D; Beer JH; Frauchiger B; Osterwalder J; Kucher N; Matter CM; Husmann M; Banyai M; Aschwanden M; Mazzolai L; Hugli O; Nagler M; Daskalakis M; Rodondi N; Aujesky D; Angelillo-Scherrer A
    J Thromb Haemost; 2019 Feb; 17(2):306-318. PubMed ID: 30570809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry.
    Yamashita Y; Yoshikawa Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
    Int J Cardiol; 2019 Oct; 292():198-204. PubMed ID: 31239211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.